Healthcare provider profile · identity verified

Edward Paul Smith, MD

Internal Medicine · WINCHESTER, VA · NPI 1447216734

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	764	145
Amlodipine Besylate	Amlodipine Besylate	724	159
Lisinopril	Lisinopril	646	141
Atorvastatin Calcium	Atorvastatin Calcium	517	131
Metformin Hcl	Metformin Hcl	399	94
Rosuvastatin Calcium	Rosuvastatin Calcium	358	94
Metoprolol Succinate	Metoprolol Succinate	329	76
Omeprazole	Omeprazole	276	67
Pravastatin Sodium	Pravastatin Sodium	256	59
Paroxetine Hcl	Paroxetine Hcl	252	48
Pantoprazole Sodium	Pantoprazole Sodium	247	63
Losartan Potassium	Losartan Potassium	242	62
Hydrochlorothiazide	Hydrochlorothiazide	212	57
Eliquis	Apixaban	201	35
Simvastatin	Simvastatin	192	41
Escitalopram Oxalate	Escitalopram Oxalate	186	44
Trulicity	Dulaglutide	174	25
Tamsulosin Hcl	Tamsulosin Hcl	172	36
Jardiance	Empagliflozin	157	29
Olmesartan Medoxomil	Olmesartan Medoxomil	150	33
Potassium Chloride	Potassium Chloride	139	31
Celecoxib	Celecoxib	131	39
Synthroid	Levothyroxine Sodium	131	28
Furosemide	Furosemide	129	39
Gabapentin	Gabapentin	128	24
Metoprolol Tartrate	Metoprolol Tartrate	124	24
Alendronate Sodium	Alendronate Sodium	116	23
Metformin Hcl Er	Metformin Hcl	111	24
Zolpidem Tartrate	Zolpidem Tartrate	102	23
Allopurinol	Allopurinol	95	27
Duloxetine Hcl	Duloxetine Hcl	94	19
Ozempic	Semaglutide	87	20
Methylprednisolone	Methylprednisolone	78	61
Sertraline Hcl	Sertraline Hcl	76	19
Buspirone Hcl	Buspirone Hcl	75	16
Ezetimibe	Ezetimibe	75	19
Glimepiride	Glimepiride	75	17
Mirtazapine	Mirtazapine	74	12
Trazodone Hcl	Trazodone Hcl	68	14
Hydralazine Hcl	Hydralazine Hcl	66	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	17
Nifedipine Er	Nifedipine	61	11
Bupropion Xl	Bupropion Hcl	57	14
Clopidogrel	Clopidogrel Bisulfate	57	12
Albuterol Sulfate Hfa	Albuterol Sulfate	55	23
Carvedilol	Carvedilol	55	12
Irbesartan	Irbesartan	52	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	11
Amoxicillin	Amoxicillin	50	43
Meloxicam	Meloxicam	50	16
Tdvax	Tetanus, Diphtheria Tox,adult	50	50
Repatha Sureclick	Evolocumab	49	11
Montelukast Sodium	Montelukast Sodium	47	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	46	suppressed
Clonazepam	Clonazepam	45	15
Ondansetron Hcl	Ondansetron Hcl	45	14
Fluoxetine Hcl	Fluoxetine Hcl	44	11
Fenofibrate	Fenofibrate Nanocrystallized	43	suppressed
Fluticasone Propionate	Fluticasone Propionate	43	14
Cefuroxime	Cefuroxime Axetil	40	38
Donepezil Hcl	Donepezil Hcl	40	14
Spironolactone	Spironolactone	40	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	26
Prednisone	Prednisone	36	18
Warfarin Sodium	Warfarin Sodium	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Verapamil Er	Verapamil Hcl	35	suppressed
Atenolol	Atenolol	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Alprazolam	Alprazolam	31	suppressed
Cephalexin	Cephalexin	30	27
Nebivolol Hcl	Nebivolol Hcl	30	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	29	29
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Azithromycin	Azithromycin	26	22
Valsartan	Valsartan	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Rivastigmine	Rivastigmine Tartrate	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Famotidine	Famotidine	23	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	15
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	12
Lansoprazole	Lansoprazole	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	16	suppressed
Topiramate	Topiramate	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Finasteride	Finasteride	14	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Ramipril	Ramipril	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	13	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Digoxin	Digoxin	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Glyburide	Glyburide	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error